AGENDA

Uniting Efforts for Innovation, Access and Delivery: A Global Dialogue

Location: Amari Watergate Hotel, Bangkok, Thailand

Date: January 30 and 31, 2019


January 30 – Formal Evening Reception (6:30 pm - 9:00 pm) - Ballroom C

Formal reception with high-level representation of Government of Japan, GHIT Fund and UNDP/ADP, as well as invited speakers. Hors d’oeuvres and drinks will be served. There will be high tables and standing room, and participants will be encouraged to move around the room and mingle. Business casual attire suggested.

Master of Ceremonies: Tenu Avafia, ADP/UNDP

Speakers:

  • Chieko Ikeda, Senior Assistant Minister for Global Health, Japan Ministry of Health, Labour and Welfare

  • Marie-Goretti Harakeye Ndayisaba, Head Social Affairs Department, African Union Commission


January 31 – Technical Meeting (8:00 am - 5:15 pm) - Ballroom C

8:00 am - 9:00 am Participant registration, distribution of materials and coffee, tea and refreshments

9:00 am - 9:30 am       Opening Remarks by Government of Japan, GHIT Fund and ADP/UNDP

9:30 am - 9:50 am       Presentation of the Backgrounder: Suerie Moon, Director of Research, Graduate Institute, Switzerland

9:50 am - 12:00 pm     PANEL 1

Ensuring returns on R&D investments: Strategies and measures to ensure that investments result in positive impact for patients in need

MODERATOR: Deborah Atherly, Global Head of Policy Access and Introduction, PATH Center for Vaccine Innovation and Access

  • Strategies to accelerate innovation and adoption of new health technologies

    • Hayato Urabe, Director, Investment Strategy, Planning & Management, GHIT Fund

  • Lessons learned in market shaping interventions and forecasting product pipelines

    • Janet Ginnard, Director, Strategy, UNITAID

  • Leveraging investment, gaps and opportunities

    • Robert Terry, Manager, Research Policy, Special Programme for Research and Training in Tropical Diseases (TDR) at WHO

  • A civil society perspective on the R&D needs for tuberculosis

    • Marcus Low, Technical Lead for Treatment at Global Tuberculosis Community Advisory Board (Global TB CAB) and SECTION27 South Africa

  • Private sector perspective on changes in funding sources & collaborative strategies

    • Elly Kourany-Lefoll, Head of Neglected Tropical Diseases, Merck

  • Transforming drug discovery

    • Jeremy Burrows, Vice President, Head of Drug Discovery, Medicines for Malaria Venture (MMV)

  • Lessons learned on incentives to promote innovation, access and delivery of health technologies

    • Damiano de Felice, Director of Strategy, Access to Medicine Foundation

12:00 pm - 1:00 pm   Lunch

1:00 pm - 2:30 pm     PANEL 2

Country Preparedness: What are the prerequisites & opportunities for access and delivery at country or regional levels

MODERATOR: Garry Aslanyan, Manager, Partnerships and Governance, Special Programme for Research and Training in Tropical Diseases (TDR) at WHO

  • Working across the value chain of access and delivery of health technologies

    • Cecilia Oh, ADP Project Coordinator, ADP-UNDP Bangkok

  • Preparing for access and delivery of health technologies

    • Khadija Yahya-Malima, Chief Research Officer, Commission of Science & Technology (COSTECH), Government of Tanzania

  • Fexinidazole & other case studies as examples of connecting access and delivery priorities through all R&D stages

    • Daisuke Imoto, Head of Office, DNDi Japan

  • The development and domestication of the AU Model Law on Medical Products Regulation

    • Janet Byaruhanga, Director, NEPAD South Africa

  • The role of implementation research in introducing a new technology

    • Margaret Gyapong, Director, Centre for Health Policy and Implementation Research, University of Health and Allied Sciences, Ghana

  • Pharmacovigilance and post-marketing strategies for new health technologies: lessons learned in the introduction of new TB medicines

    • Dwiana Andayani, Head of Sub-Directorate of Drug Safety Control, National Agency for Drug and Food Control (BPOM), Government of Indonesia

2:30 pm - 2:40 pm       Coffee break

2:40 pm - 4:00 pm       Breakaway Sessions - Working Groups

Participants will be divided into three working groups, with a moderator and rapporteur assigned to each group. Participants will be asked to brainstorm and come up with recommendations for future action/dialogues on the following topics:

  • Group 1: Financing: This group will discuss how to enhance the coordination in financing to increase investment efficiencies and leverage new funders or sources of funding.

  • Group 2: Planning for access in R&D stages: This group will discuss how to build strategic planning for access and delivery in all the stages of R&D.

  • Group 3: Preparedness for access and delivery: This group will discuss how to address key and critical issues and barriers in access and delivery preparedness in country and regional levels.

4:00 pm - 5:15 pm       Final Session: The way forward

Reflections shared by following discussants:

  • Suerie Moon, Director of Research, Graduate Institute, Switzerland      

  • Agus Purwadianto, Head of Clinical Advisory Council, Ministry of Health, Indonesia

  • Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) (TBC)

  • BT Slingsby, CEO & Executive Director, GHIT Fund

  • Tenu Avafia, Team Leader, Human Rights, Key Populations, Health Technology Innovation and Access, UNDP

  • Closing remarks from Sumi Manabu, Director, Global Health Policy Division, Japan Ministry of Foreign Affairs (MOFA)

Informal Reception & Gathering: From 5:30 - 7:00 pm - Gardenside

Hors d’oeuvres and drinks will be served. There will be high tables and standing room.